Biosense Webster has gained U.S. FDA approval for multiple cardiac ablation products, allowing a zero-fluoroscopy workflow utilizing direct imaging guidance as an alternative to reduce radiation exposure and improve safety and efficiency in atrial fibrillation treatments.